Given the PC3-CXCR4 tumor uptake of the radioligands in our bilateral tumor model, we found that the most relevant metric of evaluating these CXCR4 ligands in vitro is to measure the total cell associated activity (%IA) over 1 h. The gene discussed is CXCR4; the disease is neoplasm.